Sign Up for Vincent AI
Boehringer Ingelheim (Canada) Ltd. v. Jamp Pharma Corporation,
3 cases
Alexion Pharma v. Amgen Canada,
"...General Tire & Rubber Co v Firestone Tyre & Rubber Co, [1972] RPC 457 at 486; Takeda at para 152; Boehringer Ingelheim v JAMP, 2024 FC 1198 at para [62] As noted in Takeda at paragraph 153, disclosure may be made without any recognition of what is present or what is happening: see A..."
Adeia Guides Inc. v. Videotron Ltd., 2025 FC 1725
"...only the claims of the earlier patent and the CGK may be considered; any other prior art must be disregarded (Boehringer v JAMP, 2024 FC 1198 at paras 163, 168; Mylan v Eli Lilly, 2016 FCA 119 at para D. Infringement [50] A patented invention is used if “the defendant’s activity deprived th..."
AGI Suretrack, LLC v. Farmers Edge Inc, 2025 FCA 134
"...to consider whether any of the elements were essential or nonessential” (Boehringer Ingelheim (Canada) Ltd. v. Jamp Pharma Corporation, 2024 FC 1198, at para. 105 [Boehringer]). Furlanetto J. noted this lack of expert evidence, and the patentee’s inconsistent position on essentiality, in he..."
Try vLex and Vincent AI for free
Start a free trial2 firm's commentaries
Canadian Patent Law 2024: A Year In Review
"...Inc, 2024 FC 424. Indeed, including the term "about" may prove important. In Boehringer Ingelheim (Canada) Ltd v Jamp Pharma Corporation, 2024 FC 1198, one of the issues considered by the Federal Court was the scope of a claim defining components of a formulation in weight percentage amount..."
Let's Talk About 'about" And Numerical Data
"...to a Federal Court Decision in Canada Boehringer Ingelheim (Canada) Ltd. v. Jamp Pharma Corporation, issued on Aug. 8, 2024, Citation 2024 FC 1198, which is a recent decision involving interpretation of numerical data in claims (including single numbers and number See document.do We discuss..."
Try vLex and Vincent AI for free
Start a free trialExperience vLex's unparalleled legal AI
Access millions of documents and let Vincent AI power your research, drafting, and document analysis — all in one platform.
Start Your 3-day Free Trial of vLex and Vincent AI, Your Precision-Engineered Legal Assistant
-
Access comprehensive legal content with no limitations across vLex's unparalleled global legal database
-
Build stronger arguments with verified citations and CERT citator that tracks case history and precedential strength
-
Transform your legal research from hours to minutes with Vincent AI's intelligent search and analysis capabilities
-
Elevate your practice by focusing your expertise where it matters most while Vincent handles the heavy lifting
Start Your 3-day Free Trial of vLex and Vincent AI, Your Precision-Engineered Legal Assistant
-
Access comprehensive legal content with no limitations across vLex's unparalleled global legal database
-
Build stronger arguments with verified citations and CERT citator that tracks case history and precedential strength
-
Transform your legal research from hours to minutes with Vincent AI's intelligent search and analysis capabilities
-
Elevate your practice by focusing your expertise where it matters most while Vincent handles the heavy lifting
3 cases
Alexion Pharma v. Amgen Canada,
"...General Tire & Rubber Co v Firestone Tyre & Rubber Co, [1972] RPC 457 at 486; Takeda at para 152; Boehringer Ingelheim v JAMP, 2024 FC 1198 at para [62] As noted in Takeda at paragraph 153, disclosure may be made without any recognition of what is present or what is happening: see A..."
Adeia Guides Inc. v. Videotron Ltd., 2025 FC 1725
"...only the claims of the earlier patent and the CGK may be considered; any other prior art must be disregarded (Boehringer v JAMP, 2024 FC 1198 at paras 163, 168; Mylan v Eli Lilly, 2016 FCA 119 at para D. Infringement [50] A patented invention is used if “the defendant’s activity deprived th..."
AGI Suretrack, LLC v. Farmers Edge Inc, 2025 FCA 134
"...to consider whether any of the elements were essential or nonessential” (Boehringer Ingelheim (Canada) Ltd. v. Jamp Pharma Corporation, 2024 FC 1198, at para. 105 [Boehringer]). Furlanetto J. noted this lack of expert evidence, and the patentee’s inconsistent position on essentiality, in he..."
Try vLex and Vincent AI for free
Start a free trialStart Your 3-day Free Trial of vLex and Vincent AI, Your Precision-Engineered Legal Assistant
-
Access comprehensive legal content with no limitations across vLex's unparalleled global legal database
-
Build stronger arguments with verified citations and CERT citator that tracks case history and precedential strength
-
Transform your legal research from hours to minutes with Vincent AI's intelligent search and analysis capabilities
-
Elevate your practice by focusing your expertise where it matters most while Vincent handles the heavy lifting
Start Your 3-day Free Trial of vLex and Vincent AI, Your Precision-Engineered Legal Assistant
-
Access comprehensive legal content with no limitations across vLex's unparalleled global legal database
-
Build stronger arguments with verified citations and CERT citator that tracks case history and precedential strength
-
Transform your legal research from hours to minutes with Vincent AI's intelligent search and analysis capabilities
-
Elevate your practice by focusing your expertise where it matters most while Vincent handles the heavy lifting
2 firm's commentaries
Canadian Patent Law 2024: A Year In Review
"...Inc, 2024 FC 424. Indeed, including the term "about" may prove important. In Boehringer Ingelheim (Canada) Ltd v Jamp Pharma Corporation, 2024 FC 1198, one of the issues considered by the Federal Court was the scope of a claim defining components of a formulation in weight percentage amount..."
Let's Talk About 'about" And Numerical Data
"...to a Federal Court Decision in Canada Boehringer Ingelheim (Canada) Ltd. v. Jamp Pharma Corporation, issued on Aug. 8, 2024, Citation 2024 FC 1198, which is a recent decision involving interpretation of numerical data in claims (including single numbers and number See document.do We discuss..."